Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Amyloid Fibrils

Amyloid Fibrils

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Japanese Version of 26-Item Informant Questionnaire on Cognitive Decline in the Elderly: Development and Validation Study.

Geriatrics & gerontology international·2026

Same author

Consensus Definitions of Disease Activity and Clinical Outcomes in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Neurology·2026

Same author

Asthma-like bronchodilator responsiveness in patients with neuronal intranuclear inclusion disease.

Scientific reports·2026

Same author

Real-world outcomes after switching from standard therapy to efgartigimod in five patients with chronic inflammatory demyelinating polyradiculoneuropathy: a case series study in Japan.

Frontiers in neurology·2026

Same author

Real-World Application of Subcutaneous Efgartigimod in Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Internal medicine (Tokyo, Japan)·2026

Same author

Response to comments to "Prevalence and trajectories of post-COVID-19 neuromuscular conditions: A systematic-review and meta-analysis".

Journal of the neurological sciences·2026

Same journal

[Neuropathological Autopsies in Japan: Current Scenario and Challenges].

Brain and nerve = Shinkei kenkyu no shinpo·2026

Same journal

[Telemedicine and Digital Technologies in Neurological Intractable Diseases].

Brain and nerve = Shinkei kenkyu no shinpo·2026

Same journal

[Disaster Countermeasures for Intractable Neurological Disease].

Brain and nerve = Shinkei kenkyu no shinpo·2026

Same journal

[Supporting Health Care Transition for Patients with Childhood-Onset Chronic Conditions: Within Intractable Disease Care in Japan].

Brain and nerve = Shinkei kenkyu no shinpo·2026

Same journal

[Multidisciplinary Collaboration between Hospitals and Clinics at the University Hospital and the Core Hospital for the Treatment of Intractable Diseases].

Brain and nerve = Shinkei kenkyu no shinpo·2026

Same journal

[The Role of Coordinators for Intractable Diseases in Japan].

Brain and nerve = Shinkei kenkyu no shinpo·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Sep 11, 2025

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging

Published on: October 20, 2017

[AL Amyloidosis].

Toshihiro Ide¹, Haruki Koike

¹Department of Neurology, Saga University.

Brain and Nerve = Shinkei Kenkyu No Shinpo

|August 18, 2025

Summary

This summary is machine-generated.

Amyloid light-chain amyloidosis (AL) can cause peripheral neuropathy, mimicking other conditions. Early diagnosis and multidisciplinary care are crucial for managing this systemic disease and its neurological complications.

More Related Videos

Rapid Generation of Amyloid from Native Proteins In vitro

Rapid Generation of Amyloid from Native Proteins In vitro

Published on: December 5, 2013

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Published on: April 19, 2021

Related Experiment Videos

Last Updated: Sep 11, 2025

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging

Published on: October 20, 2017

Rapid Generation of Amyloid from Native Proteins In vitro

Rapid Generation of Amyloid from Native Proteins In vitro

Published on: December 5, 2013

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Published on: April 19, 2021

Area of Science:

Neurology
Hematology
Pathology

Background:

AL amyloidosis is a systemic disease resulting from misfolded immunoglobulin light chains.
These light chains deposit as amyloid fibrils, affecting multiple organs.
Peripheral neuropathy is a common initial manifestation, sometimes misdiagnosed.

Purpose of the Study:

To review the clinical features of AL amyloidosis-related peripheral neuropathy.
To outline diagnostic strategies and recent treatment advances.
To emphasize pathological mechanisms and the importance of early, multidisciplinary management.

Main Methods:

Literature review focusing on clinical presentation, diagnosis, and treatment.
Analysis of pathological mechanisms, including axonal degeneration.
Discussion of electrophysiological and nerve biopsy findings.

Main Results:

Peripheral neuropathy in AL amyloidosis presents with sensory dissociation and autonomic dysfunction.
It can be mistaken for chronic inflammatory demyelinating polyneuropathy.
Axonal degeneration and myelin-Schwann cell abnormalities are key pathological features.

Conclusions:

Early diagnosis of AL amyloidosis-related neuropathy is vital.
Multidisciplinary management is essential for optimal patient outcomes.
Understanding the specific pathological mechanisms aids in diagnosis and treatment.